Besides a well-known biomarker for adenocarcinoma, the serum CEA was also correlated with the severity of idiopathic pulmonary fibrosis (39–41) and serves as a powerful indicator of RP-ILD and poor prognosis in patients with CADM (42). This evidence concerns the gene CEACAM5 and adenocarcinoma.